The Ozempic Impact - Designing for Dramatically Different Dining

SHOW NOTES - EPISODE 118 Episode Summary: This groundbreaking episode examines how GLP-1 drugs like Ozempic are fundamentally transforming club dining, from kitchen economics to social dynamics, and explores innovative solutions for clubs facing this pharmaceutical revolution. Key Topics Covered: The scope of GLP-1 drug adoption among members Collapsing kitchen economics with 30-40% reduced consumption Social dining crisis and member discomfort Design modifications for new dining realities Innovative programming and pricing solutions Future implications for club F&B programs The Numbers That Matter: 15-20% of affluent Americans currently using GLP-1 drugs 30-40% projected adoption within 3 years 35% average check decline reported by clubs 70% reduction in individual food consumption 60% food waste in traditional prep models 20% of F&B revenue shifting to takeout Economic Impacts: Traditional cost structure (30-35% food, 40-45% labor) unsustainable Average per-cover loss: $12 for GLP-1 users Buffet model economics completely broken Catering guarantees no longer reliable Beverage programs facing reduced tolerance issues Design Adaptations: Physical Modifications: Smaller plate sizes (7-inch vs 12-inch) Flexible table systems "Jewelry box" buffet presentations Adjustable atmospheric lighting Smaller kitchen prep areas Precision cooking equipment for tiny portions Service Model Changes: Tapas-style flexible timing "Collections" menu format Experience-focused presentations Tableside theater emphasis Parallel wellness/traditional programs Innovative Solutions: Experience fees vs food charges Membership-inclusive dining credits Sophisticated mocktail programs Zero-proof wine pairings Educational programming emphasis Expanded takeout operations Social Dynamics: "Eaters" vs "non-eaters" divide Generational tensions over pharmaceutical use Celebration challenges with non-eating guests Wine culture crisis Business dining confusion Staff morale impacts Future Implications: Oral GLP-1 drugs will increase adoption Dining rooms becoming "social galleries" Staffing shift to nutrition specialists Technology for mass customization Fundamental questioning of F&B role Immediate Action Items: Anonymous member survey on GLP-1 usage F&B vulnerability audit Small-plate program pilot Alternative pricing model exploration Staff training on pharmaceutical impacts Menu engineering for variety over volume Design Recommendations: Invest in smaller serviceware Create flexible dining spaces Develop "social lounges" vs formal dining Plan kitchens for variety not volume Design for experience over consumption Enable multiple service models simultaneously Key Insights: "We're not just feeding bodies anymore - we're nourishing communities in entirely new ways." "The successful clubs will recognize dining as social theater where food is prop, not purpose." "This isn't a trend to weather - it's a fundamental shift in human behavior driven by pharmaceutical intervention." Warning Signs to Monitor: Declining average checks Increased food waste Member complaints about portions Staff morale issues Event attendance dropping Bar liability incidents Connect With Us: Website: golfclubhousedesign.com LinkedIn: linkedin.com/in/egcd/ Listen on Fountain: fountain.fm/show/yzI5IQdvhrChoCRj3htR